Skip to Main Content

Paper Details

HESTAT: Study protocol for a phase II/III, randomized, placebo-controlled, single blind study to evaluate the new hemostatic agent TT-173 in total knee arthroplasty.
Contemporary Clinical Trials
0
2017
hemoglobin, participants, patients, recombinant tissue factor
Author NameAffiliation
Gerard UrrútiaSant Pau Biomedical Research Institute (IIB Sant Pau), Spain CIBER Epidemiologia y Salud Publica (CIBERESP)
  • 1 - 1

Datasets

Release 1.2